US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
オーストラリア
ASX
Actinogen Medical Limited (ACW) 銘柄情報

Actinogen Medical Limited (ACW)

0.0375

-0.0005

( -1.32% )

更新日時： 09:26:30

Actinogen Medical Limited (ACW) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

0.0375

( -1.32% )

買値

0.037

売値

0.038

出来高

802,164

0.037 日の範囲 0.039

0.019 52 週間の範囲 0.072

時価総額

前日終値

0.038

始値

0.038

時刻

最終取引時間

12:18:33

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 2,960,990

発行済株式数

3,591,209,157

配当利回り

PER

-6.57

1 株当たり利益 (EPS)

-0.01

歳入

7.36M

純利益

-17.91M

Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia. It develops Xanamem, an oral medication and inhibitor of the 11ß-HSD1 enzyme that achieves target engagement in the brain fo... Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia. It develops Xanamem, an oral medication and inhibitor of the 11ß-HSD1 enzyme that achieves target engagement in the brain for the treatment of Alzheimer’s disease, major depressive disorder, fragile x syndrome, and other neurological diseases. The company was formerly known as Actinogen Limited and changed its name to Actinogen Medical Limited in November 2015. Actinogen Medical Limited was incorporated in 1999 and is based in Sydney, Australia. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

actinogen.com.au

本社

Sydney, Australia

設立

1999

Actinogen Medical Limited is listed in the Healthcare sector of the オーストラリア証券取引所 with ticker ACW. The last closing price for Actinogen Medical was AUD0.04. Over the last year, Actinogen Medical shares have traded in a share price range of AUD 0.019 to AUD 0.072.

Actinogen Medical currently has 3,591,209,157 shares in issue. The market capitalisation of Actinogen Medical is AUD134.67 million. Actinogen Medical has a price to earnings ratio (PE ratio) of -6.57.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.0025	-6.25	0.04	0.04	0.037	1948330	0.03878228	DE
4	-0.0095	-20.2127659574	0.047	0.047	0.034	3341015	0.03897089	DE
12	-0.0025	-6.25	0.04	0.048	0.0335	2867718	0.03992884	DE
26	-0.0185	-33.0357142857	0.056	0.072	0.0335	3950238	0.04725839	DE
52	0.0175	87.5	0.02	0.072	0.019	3810022	0.04073182	DE
156	-0.0085	-18.4782608696	0.046	0.099	0.015	4952228	0.03713753	DE
260	-0.0875	-70	0.125	0.1975	0.015	4075641	0.05738638	DE

ACW - Frequently Asked Questions (FAQ)

What is the current Actinogen Medical Limited share price?

The current share price of Actinogen Medical Limited is AUD 0.0375

How many Actinogen Medical Limited shares are in issue?

Actinogen Medical Limited has 3,591,209,157 shares in issue

What is the market cap of Actinogen Medical Limited?

The market capitalisation of Actinogen Medical Limited is AUD 134.67M

What is the 1 year trading range for Actinogen Medical Limited share price?

Actinogen Medical Limited has traded in the range of AUD 0.019 to AUD 0.072 during the past year

What is the PE ratio of Actinogen Medical Limited?

The price to earnings ratio of Actinogen Medical Limited is -6.57

What is the cash to sales ratio of Actinogen Medical Limited?

The cash to sales ratio of Actinogen Medical Limited is 18.53

What is the registered address of Actinogen Medical Limited?

The registered address for Actinogen Medical Limited is 109 Pitt Street, Sydney, New South Wales, 2000

What is the Actinogen Medical Limited website address?

The website address for Actinogen Medical Limited is actinogen.com.au

Which industry sector does Actinogen Medical Limited operate in?

Actinogen Medical Limited operates in the Biotechnology & Life Sciences sector

Split T

Split T 3分前

Wow, LIBOR and Ezell litigation ends and you that the price is dropping because sellers are pulling listings..lol. you might ought to rethink why the shorts are buying hand over fist.

Biotrader23

Biotrader23 6分前

Been holding sig AVXL position for the last 5 years, regulatory setbacks are common in biotech world, some of my best winners had to overcome those..

Since we have no cash/runway issues my biggest worry at the moment is the direction: Jing Ma (aka SPAC queen) firmly in charge, just lo

Nightdaytrader

Nightdaytrader 7分前

There are so many mistakes and falsehoods in this AI Project West post. Too many to comment on..

There is also this AI statement which is totally wrong. AI stated: "Releasing JPM and others from potential claims (including willful misconduct carve-outs or negotiations around them)

GreenShoots

GreenShoots 12分前

Everybody sees what you refuse to. Don’t be mad cuz you down and out. Don’t hate people that have been here for so long and NOW see the TRUTH. You wanna go down with the ship, do it. Just don’t hate people that see what is happening

skitahoe

skitahoe 13分前

I believe it the Will Rodger's simple stock advice, Buy Good Stock.
The fact that it's been down much of the time I've been in it leads to his principle that if it's up, good, if it's down, better, buy more.

If the stock had moved up from the time I first bought it, I doubt i

cadillacdave

cadillacdave 17分前

There is a high short interest here, so there will be a lot of volatility. Sell the spikes and buy the lows.

It's been a traders stock for quite some time. When big news hits and takes out the shorts, things may change here.

lakers17

lakers17 19分前

BTC back over $64,400. Trust the process, ignore the noise. It's pretty simple. Either you believe in crypto and are holding or averaging down and or you don't believe in crypto and never buy anything. Every time BTC drops the noise emerges out of the closet. I have most on ignore now. I will

JusDePomme

JusDePomme 20分前

Look for devs type move here ahead

JusDePomme

JusDePomme 21分前

Can't believe some traders attack bid after hour while PPS look stunning all day with new high

clintonj

clintonj 24分前

You could have looked it up yourself, but here you go. From Grok:

"Project West" is real — but not in the conspiratorial way the forum threads frame it.
What Project West Actually Was
Project West was JPMorgan Chase's internal code name for their contingency planning a

dinogreeves

dinogreeves 25分前

This game is so good for the mind. Kind of like TGLO.

https://investorshub.advfn.com/uimage/uploads/2026/6/3/leyzfScreenshot_2026-06-03_at_8.20.46%E2%80%AFPM.png

lakers17

lakers17 25分前

Great game. Somehow your team just finds ways to win. Brunson was amazing and Hart had 15 rebounds and 4 steals. another player the Lakers should never have let go.

JimBoStevens

JimBoStevens 28分前

ALL ABOARD??? hehe Just me and mathman to the finish line

Legend431

Legend431 30分前

At Gary’s age he is delusional

Flip it

Flip it 31分前

Disappointment is a temporary detour on way to success

HGiLS

Great analysis.

Totally agree with you.

Bionic Man

Bionic Man 32分前

Dabeav

Dabeav 32分前

I wonder why it was never mentioned by Biden govt

Bionic Man

Bionic Man 33分前

Glad I sold this junk at .0008

Bionic Man

Bionic Man 35分前

PhantomEnchanter891

PhantomEnchanter891 38分前

That would make GB happy!

jtomm

OT: I asked AI about AI. It gave surprisingly honest answers, admitting that, right now, the entire industry is pretty much aspirational hype. lol. It's not that it's not useful, but that it's being way oversold and is not "intelligent". I totally agree with that.

I asked both Google

Mozy429

Mozy429 40分前

Chart didn’t paste. But basically per FDA, most drugs similar to eliquis drop 70-90%, but due to eliquis size, market share will play a huge role. Also, The FDA’s research consistently shows:

For Eliquis specifically, investors sometimes focus too much on the eventual selling price. T

ColdDarkHole

ColdDarkHole 40分前

There is no stampede or shock the world anything coming. The only thing shocking but not surprising here will be the reverse split ratio. This is a pre-revenue company that has to raise capital to begin manufacturing.

fricassee

fricassee 40分前

The iPhone Fold

https://youtu.be/Cl5tQNRPtB0?si=yuC-5V1yVHtzBj3L

Actinogen Medical

Just Another Acquisition

Canoe Defensive Global E...

vTv Therapeutics

Artesian Resources (QB)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。